Repositori institucional URV
| Autor/s de la URV: | Bulló Bonet, Mònica / Salas Salvadó, Jorge |
| Autor segons l'article: | van Gils, Veerle; Rizzo, Marianna; Cote, Jade; Viechtbauer, Wolfgang; Fanelli, Giuseppe; Salas-Salvado, Jordi; Wimberley, Theresa; Bullo, Monica; Fernandez-Aranda, Fernando; Dalsgaard, Soren; Visser, Pieter Jelle; Jansen, Willemijn J; Vos, Stephanie J B |
| Adreça de correu electrònic de l'autor: | monica.bullo@urv.cat jordi.salas@urv.cat |
| Identificador de l'autor: | 0000-0002-0218-7046 0000-0003-2700-7459 |
| Any de publicació de la revista: | 2024 |
| Tipus de publicació: | Journal Publications |
| Referència de l'ítem segons les normes APA: | van Gils, Veerle; Rizzo, Marianna; Cote, Jade; Viechtbauer, Wolfgang; Fanelli, Giuseppe; Salas-Salvado, Jordi; Wimberley, Theresa; Bullo, Monica; Fern (2024). The association of glucose metabolism measures and diabetes status with Alzheimer's disease biomarkers of amyloid and tau: A systematic review and meta-analysis. Neuroscience And Biobehavioral Reviews, 159(), 105604-. DOI: 10.1016/j.neubiorev.2024.105604 |
| Referència a l'article segons font original: | Neuroscience And Biobehavioral Reviews. 159 105604- |
| Resum: | Conflicting evidence exists on the relationship between diabetes mellitus (DM) and Alzheimer's disease (AD) biomarkers. Therefore, we conducted a random-effects meta-analysis to evaluate the correlation of glucose metabolism measures (glycated hemoglobin, fasting blood glucose, insulin resistance indices) and DM status with AD biomarkers of amyloid-beta and tau measured by positron emission tomography or cerebrospinal fluid. We selected 37 studies from PubMed and Embase, including 11,694 individuals. More impaired glucose metabolism and DM status were associated with higher tau biomarkers (r=0.11[0.03-0.18], p=0.008; I2=68%), but were not associated with amyloid-beta biomarkers (r=-0.06[-0.13-0.01], p=0.08; I-2=81%). Meta-regression revealed that glucose metabolism and DM were specifically associated with tau biomarkers in population settings (p=0.001). Furthermore, more impaired glucose metabolism and DM status were associated with lower amyloid-beta biomarkers in memory clinic settings (p=0.004), and in studies with a higher prevalence of dementia (p |
| DOI de l'article: | 10.1016/j.neubiorev.2024.105604 |
| Enllaç font original: | https://www.sciencedirect.com/science/article/pii/S0149763424000733?via%3Dihub |
| Versió de l'article dipositat: | info:eu-repo/semantics/publishedVersion |
| Accès a la llicència d'ús: | https://creativecommons.org/licenses/by/3.0/es/ |
| Departament: | Bioquímica i Biotecnologia |
| URL Document de llicència: | https://repositori.urv.cat/ca/proteccio-de-dades/ |
| Àrees temàtiques: | Psychology Psicología Neurosciences Neuropsychology and physiological psychology Medicina veterinaria Medicina ii Medicina i Interdisciplinar Engenharias ii Educação física Cognitive neuroscience Clinical neurology Ciencias sociales Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Behavioral sciences Behavioral neuroscience |
| Paraules clau: | Vascular risk-factors Type 2 dm mellitus (t2dm) Tau Resistance (homa-ir Positron emission tomography (pet) Neurodegeneration Mini mental status examination (mmse) Mellitus Insulin-resistance Homeostatic model assessment for insulin resistance (homa-ir) Homeostatic model assessment for insulin Glycemi Glycated hemoglobin (hba1c) Glycated haemoglobin (hba1c) Fasting blood glucose (fbg) Elderly persons Effect-size Deposition Cognitive impairment Cerebrospinal-fluid biomarkers Cerebrospinal fluid (csf) Brain Amyloid-beta |
| Entitat: | Universitat Rovira i Virgili |
| Data d'alta del registre: | 2024-08-03 |
| Cerca el teu registre a: |   |
| Fitxer | Descripció | Format | |
|---|---|---|---|
| DocumentPrincipal | DocumentPrincipal | application/pdf |
© 2011 Universitat Rovira i Virgili